| Dr Kevin Scott Clive, MD | |
|
1950 Nw Myhre Rd Fl 2, Silverdale, WA 98383-7662 | |
| (564) 240-4110 | |
| (564) 240-4088 |
| Full Name | Dr Kevin Scott Clive |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 17 Years |
| Location | 1950 Nw Myhre Rd Fl 2, Silverdale, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780889808 | NPI | - | NPPES |
| 2043479 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 61486-20 (Wisconsin) | Secondary |
| 208600000X | Surgery | MD60494758 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Harrison Medical Center | Bremerton, WA | Hospital |
| Olympic Medical Center | Port angeles, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Franciscan Medical Group | 0547173866 | 1115 |
News Archive
Gut bacteria play a little-understood role in the body's energy balance, which is influenced by diet. However, the crucial nutritional components are unknown. A team at the Technical University of Munich was able to demonstrate for the very first time that mice without gastrointestinal microbiota grow obese when fed with dietary fat from plant sources, but not from animal sources.
Nektar Therapeutics today announced preliminary results from the first stage of a two-stage Phase 2 clinical study evaluating NKTR-102 in women with platinum-resistant ovarian cancer. In the first stage of the study, 39 patients enrolled with platinum-resistant disease were evaluable for the primary endpoint of overall response rate using Gynecologic Cancer InterGroup (GCIG) criteria, i.e., a combination of response by tumor imaging
The Federation of American Societies for Experimental Biology is pleased to announce the winners of the fifth annual BioArt competition.
As part of an ambitious strategy to gain market share in a medical marijuana (MMJ) sector forecast to reach $6 billion over the next five years, Neutra Corp. (OTCBB: NTRR) announced today that the first phase of development is now underway on a horticultural post-production system that could soon revolutionize the time and care needed to deliver medicinal cannabis to patients.
The President of the BBVA Foundation, Francisco Gonz-lez, Jose Baselga, Chief of Hematology/Oncology at Massachusetts General Hospital Cancer Center (MGHCC), and Andr-s de Kelety, Managing Director at the Vall d'Hebr-n Institute of Oncology (VHIO) in Barcelona, yesterday signed the agreement creating the BBVA Foundation Tumor Biomarkers Research Program.
› Verified 2 days ago
| Entity Name | Multicare Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497766638 PECOS PAC ID: 7719899897 Enrollment ID: O20031105000760 |
News Archive
Gut bacteria play a little-understood role in the body's energy balance, which is influenced by diet. However, the crucial nutritional components are unknown. A team at the Technical University of Munich was able to demonstrate for the very first time that mice without gastrointestinal microbiota grow obese when fed with dietary fat from plant sources, but not from animal sources.
Nektar Therapeutics today announced preliminary results from the first stage of a two-stage Phase 2 clinical study evaluating NKTR-102 in women with platinum-resistant ovarian cancer. In the first stage of the study, 39 patients enrolled with platinum-resistant disease were evaluable for the primary endpoint of overall response rate using Gynecologic Cancer InterGroup (GCIG) criteria, i.e., a combination of response by tumor imaging
The Federation of American Societies for Experimental Biology is pleased to announce the winners of the fifth annual BioArt competition.
As part of an ambitious strategy to gain market share in a medical marijuana (MMJ) sector forecast to reach $6 billion over the next five years, Neutra Corp. (OTCBB: NTRR) announced today that the first phase of development is now underway on a horticultural post-production system that could soon revolutionize the time and care needed to deliver medicinal cannabis to patients.
The President of the BBVA Foundation, Francisco Gonz-lez, Jose Baselga, Chief of Hematology/Oncology at Massachusetts General Hospital Cancer Center (MGHCC), and Andr-s de Kelety, Managing Director at the Vall d'Hebr-n Institute of Oncology (VHIO) in Barcelona, yesterday signed the agreement creating the BBVA Foundation Tumor Biomarkers Research Program.
› Verified 2 days ago
| Entity Name | Franciscan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093165334 PECOS PAC ID: 0547173866 Enrollment ID: O20031111000789 |
News Archive
Gut bacteria play a little-understood role in the body's energy balance, which is influenced by diet. However, the crucial nutritional components are unknown. A team at the Technical University of Munich was able to demonstrate for the very first time that mice without gastrointestinal microbiota grow obese when fed with dietary fat from plant sources, but not from animal sources.
Nektar Therapeutics today announced preliminary results from the first stage of a two-stage Phase 2 clinical study evaluating NKTR-102 in women with platinum-resistant ovarian cancer. In the first stage of the study, 39 patients enrolled with platinum-resistant disease were evaluable for the primary endpoint of overall response rate using Gynecologic Cancer InterGroup (GCIG) criteria, i.e., a combination of response by tumor imaging
The Federation of American Societies for Experimental Biology is pleased to announce the winners of the fifth annual BioArt competition.
As part of an ambitious strategy to gain market share in a medical marijuana (MMJ) sector forecast to reach $6 billion over the next five years, Neutra Corp. (OTCBB: NTRR) announced today that the first phase of development is now underway on a horticultural post-production system that could soon revolutionize the time and care needed to deliver medicinal cannabis to patients.
The President of the BBVA Foundation, Francisco Gonz-lez, Jose Baselga, Chief of Hematology/Oncology at Massachusetts General Hospital Cancer Center (MGHCC), and Andr-s de Kelety, Managing Director at the Vall d'Hebr-n Institute of Oncology (VHIO) in Barcelona, yesterday signed the agreement creating the BBVA Foundation Tumor Biomarkers Research Program.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin Scott Clive, MD 1950 Nw Myhre Rd Fl 2, Silverdale, WA 98383-7662 Ph: (564) 240-4110 | Dr Kevin Scott Clive, MD 1950 Nw Myhre Rd Fl 2, Silverdale, WA 98383-7662 Ph: (564) 240-4110 |
News Archive
Gut bacteria play a little-understood role in the body's energy balance, which is influenced by diet. However, the crucial nutritional components are unknown. A team at the Technical University of Munich was able to demonstrate for the very first time that mice without gastrointestinal microbiota grow obese when fed with dietary fat from plant sources, but not from animal sources.
Nektar Therapeutics today announced preliminary results from the first stage of a two-stage Phase 2 clinical study evaluating NKTR-102 in women with platinum-resistant ovarian cancer. In the first stage of the study, 39 patients enrolled with platinum-resistant disease were evaluable for the primary endpoint of overall response rate using Gynecologic Cancer InterGroup (GCIG) criteria, i.e., a combination of response by tumor imaging
The Federation of American Societies for Experimental Biology is pleased to announce the winners of the fifth annual BioArt competition.
As part of an ambitious strategy to gain market share in a medical marijuana (MMJ) sector forecast to reach $6 billion over the next five years, Neutra Corp. (OTCBB: NTRR) announced today that the first phase of development is now underway on a horticultural post-production system that could soon revolutionize the time and care needed to deliver medicinal cannabis to patients.
The President of the BBVA Foundation, Francisco Gonz-lez, Jose Baselga, Chief of Hematology/Oncology at Massachusetts General Hospital Cancer Center (MGHCC), and Andr-s de Kelety, Managing Director at the Vall d'Hebr-n Institute of Oncology (VHIO) in Barcelona, yesterday signed the agreement creating the BBVA Foundation Tumor Biomarkers Research Program.
› Verified 2 days ago
Dr. Daniel S Salyer, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 10452 Silverdale Way Nw, Silverdale, WA 98383 Phone: 360-307-7300 | |
Dr. Marina Cheng, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2200 Nw Myhre Road, Silverdale, WA 98383 Phone: 360-830-1100 Fax: 360-830-1283 | |
Dr. Kimberly Ming Chan, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 9800 Levin Rd Nw, Suite 204, Silverdale, WA 98383 Phone: 360-613-1335 Fax: 360-613-1329 | |
Christina Noel Weed, MD Surgery Medicare: Medicare Enrolled Practice Location: 1900 Nw Myhre Rd Fl 2, Silverdale, WA 98383 Phone: 564-240-4110 Fax: 564-240-4088 | |
Dr. Rajeev Pathak Misra, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2200 Nw Myhre Rd, Silverdale, WA 98383 Phone: 360-830-1250 Fax: 360-830-1289 | |
Dr. Angel Manuel Reyes, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1950 Nw Myhre Rd Fl 2, Silverdale, WA 98383 Phone: 564-240-4110 Fax: 564-240-4088 | |
Ty Chun, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9927 Mickelberry Rd Nw, Suite 121, Silverdale, WA 98383 Phone: 360-613-1335 Fax: 360-613-1329 |